|
Video: What is a Stock Split?
|
|
Revelation Bioscience is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses. Co.'s focus is on identifying opportunities in the cannabis industry including domestic and international businesses that are ancillary to the production, distribution and sale of cannabis as well as businesses that legally cultivate, process and/or aid in the retail distribution of cannabis. According to our REVB split history records, Revelation Biosciences has had 1 split. | |
|
Revelation Biosciences (REVB) has 1 split in our REVB split history database. The split for REVB took place on January 25, 2024. This was a 1 for 30 reverse split, meaning for each 30 shares of REVB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split.
When a company such as Revelation Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the REVB split history from start to finish, an original position size of 1000 shares would have turned into 33.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Revelation Biosciences shares, starting with a $10,000 purchase of REVB, presented on a split-history-adjusted basis factoring in the complete REVB split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
11/18/2020 |
|
End date: |
05/01/2024 |
|
Start price/share: |
$294.00 |
|
End price/share: |
$2.15 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.27% |
|
Average Annual Total Return: |
-75.97% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$73.12 |
|
Years: |
3.45 |
|
|
|
Date |
Ratio |
01/25/2024 | 1 for 30 |
|
|